Breaking News Instant updates and real-time market news.

NTDOY

Nintendo

$0.00

(0.00%)

, EA

Electronic Arts

$129.86

-2.68 (-2.02%)

12:35
05/15/18
05/15
12:35
05/15/18
12:35

Game On: Analysts boost EA price targets after earnings beat

Welcome to "Game On," The Fly's weekly recap of the stories powering up or beating down video game stocks. NEW RELEASES: This week's big release is an enhanced port of "Hyrule Warriors," a hack-and-slash action game based on the "Legend of Zelda" franchise, for the Nintendo Switch (NTDOY). The game, which was also published by Nintendo, launches on the Switch worldwide on May 18. EA EARNINGS: Last week, Electronic Arts (EA) reported better than expected results for the fourth quarter and provided an outlook for the first quarter and fiscal 2019. In addition, the company announced a new $2.4B stock repurchase program. Following the report, Piper Jaffray analyst Michael Olson backed an Overweight rating on the stock and raised his price target for the shares to $148 from $145, saying that EA's initial earnings guidance has understated final results by an average of 11% over the past three years. As such, Olson believes the game maker's initial FY19 guidance is likely conservative. In addition, analysts from Wedbush, Oppenheimer, and MKM Partners all raised their price targets on EA's stock following the quarterly report. HANGAR 13 EXPANSION: Before the market open, 2K and Hangar 13 announced the expansion of Hangar 13 in Brighton, U.K. The new office will be headed by U.K. game development veteran Nick Baynes, and will collaborate with the teams in Novato, California and the Czech Republic across all aspects of development on all future Hangar 13 projects. Hangar 13, a division of Take-Two's (TTWO) 2K Games, launched its debut title "Mafia III" in late 2016 to mixed reviews. CONSOLE WARRANTY UPDATES: After the FTC warned six major companies, including Microsoft (MSFT), Nintendo, and Sony (SNE), that some of their product warranties may be in violation of federal law, the console makers each responded by updating their warranty terms. Last Wednesday, Sony Interactive announced that it updated the terms of its Limited Warranties for PlayStation 4, PlayStation VR, PlayStation 3, and PlayStation Vita systems sold in the United States and Canada. The same day, Kotaku reported that Nintendo made changes to the warranty language on its site, now including a passage saying that the warranty only doesn't apply to damage caused by non-Nintendo products. Last Friday, Microsoft told GamesIndustry.biz that it had updated its warranties, saying they wanted to "clarify that having your device repaired by a third party, opening your console, or breaking the seal will not void the warranty."

NTDOY

Nintendo

$0.00

(0.00%)

EA

Electronic Arts

$129.86

-2.68 (-2.02%)

TTWO

Take-Two

$112.77

-1.43 (-1.25%)

MSFT

Microsoft

$96.91

-1.13 (-1.15%)

SNE

Sony

$47.40

-0.95 (-1.96%)

  • 16

    May

  • 03

    Jun

NTDOY Nintendo
$0.00

(0.00%)

11/13/17
BMOC
11/13/17
UPGRADE
Target $200
BMOC
Market Perform
Nvidia upgraded to Market Perform at BMO Capital on strong data center business
As noted earlier, BMO Capital analyst Ambrish Srivastava upgraded Nvidia to Market Perform from Underperform and raised his price target to $200 from $135. Srivastava says the company has demonstrated a "far stronger" data center business than he had forecast and its leverage is greater than anticipated. The analyst adds that his prior negative view was based on anticipated deceleration in the gaming industry, however the business wins at Nintendo and help from the cryptocurrency market allowed Nvidia to achieve higher levels that expected.
04/20/18
PIPR
04/20/18
NO CHANGE
PIPR
March NPD video game software sales fell 25%, says Piper Jaffray
March NPD video game software sales declined 25% year-over-year due to a tough compare with the launch of Nintendo's (NTDOY) Switch console a year ago and its highly successful launch title, The Legend of Zelda, Piper Jaffray analyst Michael Olson tells investors in a research note. The top two titles in the month were Ubisoft's Far Cry 5 and Sony's (SNE) MLB: The Show, but combined, the two generated less revenue than last year's Zelda, Olson adds. He views this month's data as less relevant given the absence of a major launch from Activision Blizzard (ATVI), Electronic Arts (EA) or Take-Two (TTWO). However, Olson thinks the March NPD data is most positive for Activision and least favorable for EA, which he says faced difficult compares to the launch of Mass Affect: Andromeda the prior year. The analyst keeps Overweight ratings on Activision, EA and Take-Two.
01/19/18
BOFA
01/19/18
NO CHANGE
Target $275
BOFA
Buy
Nvidia price target raised to $275 from $251 at BofA/Merrill
BofA Merrill Lynch analyst Vivek Arya raised his calendar 2018 EPS estimate for Nvidia (NVDA) by 5% and his calendar 2019 estimate by about 10%, citing December online gamer data that points to a large upgrade opportunity for Nvidia cards, upside in high performance computing that was highlighted in TSMC's (TSM) Q4 report and continued strength in cryptocurrency and Nintendo (NTDOY) Switch sale. Arya increased his price target on Nvidia shares to $275 from $251 and keeps a Buy rating on Nvidia, which he continues to identify as a top pick.
12/07/17
BARD
12/07/17
NO CHANGE
BARD
Data so far suggesting healthy holiday game sales, says Baird
Baird analyst Colin Sebastian noted that French game maker Ubisoft (UBSFY) raised its revenue and margin guidance for the December quarter, which he views as a slight positive for video game industry sales momentum this holiday season. Data also point to solid sales for both Sony's (SNE) PS4 and Nintendo's (NTDOY) Switch, which are a driver of software as well as a key catalyst for Gamestop (GME), Sebastian added. Other publicly traded companies in the video game space include Activision Blizzard (ATVI), Electronic Arts (EA), Take-Two (TTWO) and Microsoft (MSFT).
EA Electronic Arts
$129.86

-2.68 (-2.02%)

05/09/18
OPCO
05/09/18
NO CHANGE
Target $140
OPCO
Outperform
Electronic Arts price target raised to $140 from $130 at Oppenheimer
Oppenheimer analyst Andrew Uerkwitz raised his price target for Electronic Arts to $140 from $130 after another "solid" quarter. The analyst believes the company is in a "solid position" to keep delivering high-single/double-digits net booking/non-GAAP EPS growth with free cash flow of $1.8B per year. Uerkwitz reiterates an Outperform rating on the shares.
05/09/18
MKMP
05/09/18
NO CHANGE
Target $144
MKMP
Buy
Electronic Arts price target raised to $144 from $137 at MKM Partners
MKM Partners analyst Eric Handler raised his price target on Electronic Arts to $144 and kept his Buy rating after the company's "solid" Q4 earnings beat "across all key metrics". The analyst further notes that the company's initiated FY19 non-GAAP EPS view of $4.85 was likely "conservative" and sees "multiple levers" that can drive its outperformance.
05/09/18
STFL
05/09/18
NO CHANGE
Target $141
STFL
Buy
Electronic Arts guidance looks conservative, says Stifel
Stifel analyst Drew Crum said he thinks Electronic Arts reported a "solid end" to FY18 and he believes the company's in-line FY19 guidance appears conservative given he sees the company entering a period of accelerating growth. Crum maintains his Buy rating and $141 price target on EA shares.
05/09/18
BARD
05/09/18
NO CHANGE
Target $148
BARD
Outperform
Electronic Arts results driven by strong digital performance, says Baird
Baird analyst Colin Sebastian said the Electronic Arts Q4 results were once again driven by the strength of its digital and the ongoing strength of live services. He said the strength is consistent with the company's long-term growth initiatives. Sebastian reiterated his Outperform rating and $148 price target on Electronic Arts shares.
TTWO Take-Two
$112.77

-1.43 (-1.25%)

04/30/18
04/30/18
UPGRADE
Target $126

Outperform
Take-Two upgraded to Outperform at Wedbush
As previously reported, Wedbush analyst Michael Pachter upgraded Take-Two to Outperform from Neutral, with a $126 price target, saying the shares present a compelling value, with the recent selloff overdone.
05/04/18
MSCO
05/04/18
NO CHANGE
Target $75
MSCO
Overweight
Activision Q1 report bullish for Take-Two, Electronic Arts, says Morgan Stanley
Morgan Stanley analyst Brian Nowak believes there was some impact on Activision Blizzard (ATVI), notably on Call of Duty, in Q1 from Fortnite, though that impact was less than feared, which he sees as a bullish sign for Take-Two (TTWO) and Electronic Arts (EA). In a note entitled "Could Fortnite End Up Being a Good Thing?," Nowak adds that Fortnite's success speaks to how a first person shooter can be monetized on a mobile screen, which he calls "a meaningful opportunity" for the Call of Duty franchise. Nowak keeps an Overweight rating and $75 price target on Activision Blizzard shares.
04/30/18
STFL
04/30/18
NO CHANGE
Target $131
STFL
Buy
Take-Two pullback a buying opportunity, says Stifel
Stifel analyst Drew Crum previewed Take-Two's upcoming earnings report, trimming his estimates to now be positioned at the lower-end of the range as he finds it difficult to ascertain whether there was Fortnite cannibalization, just a moderating trend line for key franchises, or a combination of both during the quarter. However, while he acknowledges some near-term risk, Crum remains bullish on Take-Two's FY19 and would use recent weakness to initiate or add to positions. He lowered his price target on Take-Two to $131 to $135 and keeps a Buy rating on the shares.
04/30/18
WEDB
04/30/18
UPGRADE
WEDB
Outperform
Take-Two upgraded to Outperform from Neutral at Wedbush
MSFT Microsoft
$96.91

-1.13 (-1.15%)

04/27/18
04/27/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Facebook (FB) upgraded to Buy from Hold at Stifel with analyst Scott Devitt acknowledging that he was wrong to have stuck with his recent view on Facebook following its first earnings report. 2. Microsoft (MSFT) upgraded to Overweight from Neutral at JPMorgan with analyst Mark Murphy saying the global movement toward multi-cloud architectures will benefit Microsoft's Azure. 3. Bristol-Myers (BMY) upgraded to Market Perform from Underperform at BMO Capital with analyst Alex Arfaei saying his concerns around the uncertainty of Opdivo sales erosion are mostly priced in, anticipating a 7% sales growth for the drug in 2019 and hoping for "more competitive" 1L-NSCLC readout that the recently disappointing IO data. 4. Nike (NKE) upgraded to Buy from Hold at HSBC. 5. Intel (INTC) upgraded to Market Perform from Underperform at Bernstein with analyst Stacy Rasgon citing the company's "very strong" Q1 report. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/10/18
FBCO
05/10/18
NO CHANGE
Target $115
FBCO
Outperform
Microsoft continues to leverage penetration in enterprise, says Credit Suisse
Credit Suisse analyst Michael Nemeroff says that Microsoft continues to leverage its existing and deep penetration in the enterprise to further distance itself among its technology peers by incorporating AI and ML into its dominant suite of productivity applications. The analyst reiterates an Outperform rating and $115 price target on the shares.
05/15/18
NEED
05/15/18
NO CHANGE
Target $49
NEED
Buy
Mimecast price target raised to $49 from $46 at Needham
Needham analyst Alex Henderson raised his price target on Mimecast (MIME) to $49 and kept his Buy rating after its "strong" Q4 results and initial FY19 guidance. The analyst notes that the wider than expected loss was in part due to the costs around the company's move to Lexington headquarters. Henderson adds that the upcoming quarter will be the first under the ASC 606 model, which should weigh on revenues but also add "solidly" to operating margins. The analyst is also positive on Mimecast's expansion in Europe following a "smooth" build-out in Germany, while its partnership with Microsoft (MSFT) is not changing despite the comments made regarding security around Office 365.
04/27/18
JPMS
04/27/18
UPGRADE
Target $110
JPMS
Overweight
JPMorgan upgrades Microsoft to Overweight with $110 price target
JPMorgan analyst Mark Murphy upgraded Microsoft to Overweight from Neutral and raised his price target for the shares to $110 from $94 following last night's Q3 results. The stock in premarket trading us up 4%, or $3.68, to $97.94. The global movement toward multi-cloud architectures will benefit Microsoft's Azure, Murphy tells investors in a research note. Further, he believes the company's "linkage to large digital transformation initiatives" and favorable positioning for hybrid cloud architectures create potential for additional upside.
SNE Sony
$47.40

-0.95 (-1.96%)

05/07/18
UBSW
05/07/18
DOWNGRADE
UBSW
Neutral
Sony downgraded to Neutral from Buy at UBS
01/23/18
JPMS
01/23/18
DOWNGRADE
JPMS
Neutral
Sony downgraded to Neutral from Overweight at JPMorgan
01/23/18
01/23/18
DOWNGRADE

Neutral
Sony downgraded to Neutral on slowing dual-cam adoption at JPMorgan
As previously reported, JPMorgan downgraded Sony (SNE) to Neutral from Overweight, citing slowing adoption of dual-cams. The firm notes that reports indicate Apple's (AAPL) iPhone 6.05" LCD model will not have a dual-cam feature, which it sees presenting a material downside risk in dual-camera adoption in the second half of 2018.

TODAY'S FREE FLY STORIES

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

14:32
09/22/18
09/22
14:32
09/22/18
14:32
Periodicals
Comcast outbids Fox in battle for Sky, Reuters reports »

Comcast (CMCSA; CMCSK)…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

, COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

13:36
09/22/18
09/22
13:36
09/22/18
13:36
Conference/Events
CoBiz Financial to host special shareholder meeting »

Special Shareholder…

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

AMRH

AMERI Holdings

$1.44

-0.04 (-2.70%)

13:30
09/22/18
09/22
13:30
09/22/18
13:30
Conference/Events
AMERI Holdings to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BRK.A

Berkshire Hathaway

$331,710.00

-1090 (-0.33%)

13:26
09/22/18
09/22
13:26
09/22/18
13:26
Periodicals
Berkshire Hathaway still looks underpriced, Barron's says »

Class A shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLGO

BioLargo

$0.00

(0.00%)

13:11
09/22/18
09/22
13:11
09/22/18
13:11
Conference/Events
BioLargo to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZWI

Citizens Community Bancorp

$14.13

0.03 (0.21%)

12:56
09/22/18
09/22
12:56
09/22/18
12:56
Conference/Events
Citizens Community Bancorp to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SF

Stifel Financial

$54.86

-0.78 (-1.40%)

12:50
09/22/18
09/22
12:50
09/22/18
12:50
Conference/Events
Stifel Financial to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBCT

People's United

$17.94

-0.055 (-0.31%)

, FBNK

First Connecticut

$30.95

0.1 (0.32%)

12:47
09/22/18
09/22
12:47
09/22/18
12:47
Conference/Events
First Connecticut to host special shareholder meeting »

Special shareholder…

PBCT

People's United

$17.94

-0.055 (-0.31%)

FBNK

First Connecticut

$30.95

0.1 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 18

    Oct

ASPS

Altisource

$34.10

-0.09 (-0.26%)

12:44
09/22/18
09/22
12:44
09/22/18
12:44
Conference/Events
Altisource to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, CSCO

Cisco

$48.51

0.77 (1.61%)

12:36
09/22/18
09/22
12:36
09/22/18
12:36
Periodicals
Apple, Microsoft among stocks with solid dividends, Barron's says »

Technology stocks are not…

AAPL

Apple

$217.65

-2.35 (-1.07%)

CSCO

Cisco

$48.51

0.77 (1.61%)

IBM

IBM

$151.29

0.12 (0.08%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

ORCL

Oracle

$51.08

0.65 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 10

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Nov

  • 03

    Mar

CAT

Caterpillar

$156.39

0.38 (0.24%)

, AMAT

Applied Materials

$39.62

0.22 (0.56%)

12:28
09/22/18
09/22
12:28
09/22/18
12:28
Periodicals
Caterpillar, KeyCorp among stocks to buy as bond yields rise, Barron's says »

As the economy improves,…

CAT

Caterpillar

$156.39

0.38 (0.24%)

AMAT

Applied Materials

$39.62

0.22 (0.56%)

BWA

BorgWarner

$45.24

-0.53 (-1.16%)

KEY

KeyCorp

$20.78

0.02 (0.10%)

PH

Parker-Hannifin

$190.52

0.01 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

  • 18

    Oct

  • 25

    Oct

  • 30

    Oct

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

, ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

10:34
09/22/18
09/22
10:34
09/22/18
10:34
Periodicals
'Good time' to think about device markers, Barron's says »

Medical technology stocks…

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

TLRY

Tilray

$123.16

-53.365 (-30.23%)

10:20
09/22/18
09/22
10:20
09/22/18
10:20
Periodicals
Marijuana stocks 'the new Bitcoin,' Barron's says »

Led by Tilray, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, WMT

Walmart

$95.85

0.1 (0.10%)

09:05
09/22/18
09/22
09:05
09/22/18
09:05
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$217.65

-2.35 (-1.07%)

WMT

Walmart

$95.85

0.1 (0.10%)

DE

Deere

$152.82

-1.24 (-0.80%)

AGCO

Agco

$60.24

-0.9 (-1.47%)

ADM

Archer Daniels

$50.33

(0.00%)

MOS

Mosaic

$32.33

0.02 (0.06%)

CF

CF Industries

$52.82

-0.48 (-0.90%)

SPWR

SunPower

$7.88

-0.18 (-2.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

  • 06

    Nov

  • 13

    Nov

  • 15

    Nov

  • 03

    Mar

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

, AGN

Allergan

$191.34

-1.11 (-0.58%)

04:55
09/22/18
09/22
04:55
09/22/18
04:55
Conference/Events
European Society of Retina Specialists to hold a conference »

18th Congress of EURETINA…

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

AGN

Allergan

$191.34

-1.11 (-0.58%)

ALIM

Alimera Sciences

$1.07

(0.00%)

BABY

Natus Medical

$34.45

-0.2 (-0.58%)

BHC

Bausch Health

$24.92

-0.07 (-0.28%)

BAYRY

Bayer

$0.00

(0.00%)

ELXMF

Ellex Medical Lasers

$0.00

(0.00%)

GKOS

Glaukos

$58.78

-1.69 (-2.79%)

IRIX

IRIDEX

$6.52

0.08 (1.24%)

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

NVS

Novartis

$85.46

-0.505 (-0.59%)

OCUL

Ocular Therapeutix

$6.45

0.03 (0.47%)

RHHBY

Roche

$0.00

(0.00%)

SHPG

Shire

$178.32

-1.68 (-0.93%)

STAA

STAAR Surgical

$47.00

-0.9 (-1.88%)

TMDI

Titan Medical

$2.24

0.02 (0.90%)

TTNP

Titan Pharmaceuticals

$0.22

-0.2833 (-56.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 09

    Oct

  • 16

    Oct

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 15

    Nov

  • 27

    Nov

  • 21

    Dec

  • 28

    Dec

  • 15

    Feb

  • 25

    Feb

CDTI

CDTi

$0.34

0.01 (3.08%)

18:15
09/21/18
09/21
18:15
09/21/18
18:15
Hot Stocks
CDTi sees September 21 as effective date of reverse stock split »

CDTi Advanced Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$79.82

-0.81 (-1.00%)

18:08
09/21/18
09/21
18:08
09/21/18
18:08
Hot Stocks
Duke Energy restored nearly 1.8M outages in NC, SC during past week »

Duke Energy crews today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 11

    Nov

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

18:01
09/21/18
09/21
18:01
09/21/18
18:01
Hot Stocks
Johnson & Johnson's Janssen discloses phase 3 study results of Esketamine »

The Janssen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 28

    Oct

UAL

United Continental

$89.94

0.8 (0.90%)

17:39
09/21/18
09/21
17:39
09/21/18
17:39
Periodicals
United pilots refuse contract changes on regional routes, Reuters says »

United Airlines pilots…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

, XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

17:36
09/21/18
09/21
17:36
09/21/18
17:36
General news
Week ending ETF Scorecard: Materials outperform, Utlilites slump »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

IYR

DJ US Real Estate Index Fund

$81.88

-0.06 (-0.07%)

XLP

Consumer Staples Sector SPDR

$55.02

0.1285 (0.23%)

XLY

Consumer Discretionary Sector SPDR

$116.98

-0.4288 (-0.37%)

XLB

S&P Select Materials SPDR

$60.54

-0.1312 (-0.22%)

XLF

Financial Select Sector

$28.73

-0.1175 (-0.41%)

XLV

Health Care Select Sector SPDR

$94.26

0.1571 (0.17%)

XLK

Technology Select Sector SPDR

$74.68

-0.2056 (-0.27%)

XLI

Industrial Select Sector SPDR

$79.71

0.2338 (0.29%)

GLD

SPDR Gold Trust

$113.48

-0.77 (-0.67%)

SLV

iShares Silver Trust

$13.44

-0.01 (-0.07%)

USO

United States Oil Fund

$14.95

0.145 (0.98%)

UNG

United States Natural Gas Fund

$24.60

0.235 (0.96%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.24

0.05 (0.06%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$114.72

0.04 (0.03%)

TLT

iShares 20+ Year Treasury Bond Fund

$117.12

-0.02 (-0.02%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.00

0.03 (0.03%)

SHY

iShares 1-3 Year Treasury Bond

$83.05

0.02 (0.02%)

IWD

iShares Russell 1000 Value

$129.51

0.13 (0.10%)

IWF

iShares Russell 1000 Growth

$155.30

-0.55 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHGI

One Horizon Group

$0.18

-0.0088 (-4.63%)

17:34
09/21/18
09/21
17:34
09/21/18
17:34
Syndicate
Breaking Syndicate news story on One Horizon Group »

One Horizon Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.41

-0.033 (-7.38%)

17:31
09/21/18
09/21
17:31
09/21/18
17:31
Syndicate
Breaking Syndicate news story on Cytori Therapeutics »

Cytori Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEM

Newmont Mining

$31.56

0.05 (0.16%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Syndicate
Breaking Syndicate news story on Newmont Mining »

Newmont Mining files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Oct

CB

Chubb

$139.87

-0.05 (-0.04%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Hot Stocks
Chubb CEO Greenberg sells $8.6M in common stock »

Chubb CEO Evan Greenberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTVT

vTv Therapeutics

$0.80

0.0096 (1.21%)

17:21
09/21/18
09/21
17:21
09/21/18
17:21
Hot Stocks
vTv says FDA advised that azeliragon efficacy be shown in at least 2 trials »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.